{
    "nctId": "NCT04142476",
    "briefTitle": "Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer",
    "officialTitle": "Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 133,
    "primaryOutcomeMeasure": "Patient compliance",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Woman, over 18 years old.\n2. With non-metastatic breast cancer.\n3. Treated by hormone therapy, regardless of the molecule (cancer RH positive).\n4. In primary prescription of hormone therapy.\n5. First prescription by a medical oncologist, surgeon or radiation therapist from the CGFL.\n6. Pharmacy of the patient located in the perimeter defined in the context of the study (Residents in the Burgundy region between a triangle delimited by the towns of Chatillon sur Seine, Dole and Chalon sur Saone.\n7. Woman who received information about the study and gave her written consent.\n8. Affiliation to a social security scheme.\n9. Participant Agreement of the referent city pharmacy of the patient.\n\nExclusion Criteria:\n\n1. Metastatic patient.\n2. Patient participating in another epidemiological or clinical study of adherence and / or hormone therapy.\n3. Patient under guardianship, curatorship or safeguard of justice.\n4. Patient with severe psychiatric disorders or who does not speak the French language\n5. Refusal to participate in the study.\n6. Refusal of participation of the referent city pharmacy of the patient.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}